The current study focuses on the roles of LPCAT1 in EGFR-mutated NSCLC cells, but the effects of LPCAT1 in KRAS-mutated NSCLC cell lines (A549 and H460) have not been explored. Here, EGFR is linked to non-small cell lung carcinoma.